SV Health Investors
Presencia
Ejecutivos
Ver el organigrama con sus 30 ejecutivos principales
Biografías más buscadas en SV Health Investors
- Eugene Hill, Chairman of the Board
- Mike Ross, Managing Partner, Biotechnology
- Brent Faduski, Chief Financial Officer, Chief Compliance Officer a...
Recientes movimientos de ejecutivos en SV Health Investors
- Nikola Trbovic que ha sido Partner, Biotechnology, ha ascendido a Managing Partner, Biotechnology (noticia publicada el 8 de enero de 2024).
- Jamil Beg, se ha incorporado a la empresa como Partner, Biotechnology (noticia publicada el 8 de enero de 2024).
Crear su alerta
para seguir los movimientos de los ejecutivos en SV Health Investors.
Fondo
SV Health Investors tiene 1.474 competidores entre los que se incluyen Lloyds Development Capital (Reino Unido), BlackRock (Estados Unidos) y WindRose Health Investors (Estados Unidos).
Popular M&A news in Fondo
- Abrdn Private Equity Opportunities Trust cambiará su nombre a Patria Capital Partners. (publicado el 30 de abril de 2024).
- HMC Capital ha StratCap adquirido (publicado el 28 de febrero de 2024).
- Thomvest Ventures acaba de anunciar una recaudación de fondos de 250 millones de dólares. (publicado el 17 de enero de 2024).
Otros contactos sugeridos en el sector Fondo
- Antonio Gracias - Founder, Chief Executive Officer and Chief Investment Officer en Valor Equity Partners
- Mortimer Buckley - Chairman of the Board and Chief Executive Officer (retiring in Dec 2024) en Vanguard
- Jean-Marc Arbaud - President and Chief Executive Officer of CDPQ Infra en Caisse de Dépôt et Placement du Québec
Noticias
Últimos comunicados de prensa de SV Health Investors
- SV Biotech launches its inaugural ESG and Impact Report - SV Health Investors
- Cumulus Neuroscience Receives Innovate UK Small Business Research Initiative (SBRI) Grant Focused on Clinical Biomarker Tools and Technologies for Dementia - SV Health Investors
- UK dementia adviser [Ruth McKernan] wants half a million volunteers for clinical trials - SV Health Investors
- Dementia Discovery Fund Look Ahead: 2024 is shaping up to be another big year in the fight against dementia - SV Health Investors
- Nitrase Therapeutics Unveils Pioneering Antibody Candidate for Parkinson’s Disease Based on Nitration Discovery in Oral Presentation at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference - SV Health Investors
- Prilenia Plans to Submit Marketing Authorization Application (MAA) in the EU for Pridopidine in Huntington’s Disease - SV Health Investors
- Cumulus Neuroscience Announces First Patient Enrolled in AccelADx Electroencephalogram (EEG) Study for Early Detection of Alzheimer's Dementia - SV Health Investors
- Ribometrix to Present New Preclinical Data From RNA-Modulating Small Molecule Programs Targeting eIF4E and c-MYC at the 2024 AACR Annual Meeting - SV Health Investors
- News - SV Health Investors
- SV Venture Partner Ruth McKernan reflects on the achievemtns of - SV Health Investors
- View more press releases Close
Redes sociales sobre SV Health Investors
- SV Health Investors en Wikipedia, Google News y Yahoo Finance
- SV Health Investors en LinkedIn, Twitter y YouTube
Ponerse en contacto
Contactar a través de e-mail con sus ejecutivos Eugene Hill 
Llame a SV Health Investors al +44 207...
